Remove 2024 Remove Disease Remove DNA Remove Molecular Biology
article thumbnail

How 3D genomics can accelerate personalised medicine

Drug Discovery World

3D genome folding DNA within the cell nucleus is more than the simple linear thread of primary sequence; it is tightly packed and folded non-randomly in a cell-type specific manner. Thus, most disease-associated regions (~95%) are found in the non-coding human genome, and a large proportion of these carry the hallmarks of enhancers 1.

DNA 130
article thumbnail

Medicinal Chemistry In The Age Of Artificial Intelligence

LifeSciVC

But that initial quote isn’t from 2024, it is from an interview in 2021 with Mark Levin, CEO at Millennium (MIT Technology Review). In fact, it increased the requirement for experienced biologists to use the new genomic information and combine it with mechanistic biology to derive new therapeutic insights. One final parallel to 2001.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Q&A With Dr. Norbert Makori and Pierre Jolicoeur: The Benefits of Combining Preclinical and Bioanalytical for Your Gene Therapy Studies

Alta Sciences

Norbert Makori and Pierre Jolicoeur: The Benefits of Combining Preclinical and Bioanalytical for Your Gene Therapy Studies pmjackson Fri, 03/01/2024 - 22:20 Recent advances in gene therapy have allowed for diseases to be approached differently.

article thumbnail

Internships at Altasciences: Q&A With Our Summer Interns

Alta Sciences

Internships at Altasciences: Q&A With Our Summer Interns nbartlett Thu, 08/22/2024 - 04:44 Internships at Altasciences are more than just a stepping stone—they’re a gateway to real-world-experience and professional growth, giving the next generation opportunities to help shape progress in the drug development industry.

article thumbnail

The future outlook for mRNA therapies

Drug Discovery World

Whilst research into mRNA has been ongoing for decade, interest has sparked in recent years and research has begun to expand into areas of vaccinology, infectious diseases and other indications. If the body fails to make the right protein, diseases such as cancer, type II diabetes, neurological conditions, and metabolic diseases can occur.

Therapies 130
article thumbnail

What to expect from PEGS Europe 2023: Day 2

Drug Discovery World

Ahead of protein and antibody engineering conference PEGS Europe 2024 in Lisbon, DDW’s Megan Thomas looks at what to expect from each track of the annual biologics technology meeting. Klaus Wagenbauer, PhD, Founder & CEO, Plectonic, on: ‘Programmable DNA-origami-based T cell engagers: PTE’.

article thumbnail

Scaling Phage Therapy

Codon

alone, according to the Centers for Disease Control and Prevention. Some algorithms simply look for important similarities between phage and bacterial DNA sequences, a signal of the extensive gene-swapping that goes on when a particular virus and bacteria have shared history. The tech for this process already exists.

Therapies 118